Casdatifan not checked

Arcus Biosciences · AB521

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
7 in total · 2 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Participants will receive a 100 mg single oral dose of casdatifan.”In the company’s words, NCT07751250 on ClinicalTrials.gov
Tested for
Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma, Hepatic Impairment, Clear Cell Renal Cell Carcinoma, Solid Tumors
Main trialPhase 3
“The purpose of the study is to evaluate the progression-free survival (PFS) of casdatifan versus placebo when each is given in combination with cabozantinib for patients who received anti-PD-1 or anti-PD-L1 therapy as part of the most recent regimen (either adjuvant monotherapy or first-line in combination with anti-CTLA-4 or VEGFR-TKI), with no more than 1 prior regimen in the metastatic setting.”In the company’s words, NCT07011719 on ClinicalTrials.gov
Other names
AB521

Other drugs for Advanced Clear Cell Renal Cell Carcinoma

All 16 drugs for Advanced Clear Cell Renal Cell Carcinoma

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Apr 2028 Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 1Recruiting May 2027 Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic Function
Phase 1Recruiting Mar 2029 A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Phase 1Completed 17 Feb 2023 Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile With Oral AB521 in Healthy Volunteers
Phase 1Completed 31 Oct 2023 A Relative Bioavailability Study and Food Effect Study of AB521 in Healthy Adult Volunteers
Phase 1Completed 18 Oct 2025 Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29)
Phase 1Completed 3 Jul 2026 A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Casdatifan

Following is part of Solo: you see every change to Casdatifan the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in